Anti-PD-1 monoclonal antibody + LCB84

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Anti-PD-1 monoclonal antibody + LCB84
Treatment and conditionWhere it standsTrials
Anti-PD-1 monoclonal antibody + LCB84 for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Anti-PD-1 monoclonal antibody + LCB84 for glioblastomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Anti-PD-1 monoclonal antibody + LCB84 for squamous cell carcinoma of head and neckPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Anti-PD-1 monoclonal antibody + LCB84 for uterine cervical neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1